Procter & Gamble Health Limited

NSE: PGHL · Healthcare

₹5,556.00-0.87%06 Nov 2026

Ask the data

Instant answers about Procter & Gamble Health Limited — computed from its filings, no language model

Market cap₹9,223 cr

Current price₹5,556.00

High / Low₹6,918 / ₹4,779

P/E24.3

P/B14.02

Book value₹396.4

ROE57.7%

ROCE79.3%

Debt / equity0.00

Dividend yield3.69%

EPS (TTM)₹228.83

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 7 periods

	Dec '18	Dec '19	Jun '21	Jun '22	Jun '23	Jun '24	FY26
Revenue	849	927	1,009	1,114	1,230	1,151	1,408
EBITDA	147	204	246	268	324	306	457
Operating margin	17.4%	22.0%	24.4%	24.1%	26.3%	26.6%	32.4%
Interest	0	0	1	0	1	1	1
Depreciation	20	17	30	28	27	27	24
Profit before tax	158	234	233	253	314	273	450
Tax	56	76	56	61	85	72	123
Net profit	0	159	177	193	229	201	327
EPS ₹	505.27	95.64	106.50	116.00	138.23	121.07	196.94
Operating cash flow	—	—	247	170	236	228	338
Capex	—	—	53	38	42	22	16
Dividend paid	—	—	382	284	94	415	340
Total assets	—	—	—	894	1,101	794	841
Equity	—	—	—	616	751	538	525

Quarterly performance

last 32 quarters · ₹ crore

showing latest 8 of 32 periods

	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25*	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	220	226	204	231	234	225	237	264	240	219	285	273	278	268	296	298	310	321	301	305	310	252	284	313	310	1	339	325	374	370	364	382
Operating profit	50	58	15	50	55	50	49	78	89	31	48	78	62	69	60	91	110	78	45	89	102	67	48	114	123	-43	90	120	110	136	100	152
Operating margin	22.7%	25.7%	7.5%	21.7%	23.3%	22.2%	20.7%	29.6%	36.9%	14.0%	17.0%	28.6%	22.3%	25.7%	20.2%	30.5%	35.6%	24.2%	15.0%	29.1%	32.8%	26.7%	17.0%	36.4%	39.8%	-3484.4%	26.7%	37.0%	29.5%	36.6%	27.4%	39.8%
Other income	6	6	7	18	17	7	6	7	6	3	2	3	5	2	3	3	5	5	5	6	5	2	2	3	4	-1	4	5	4	4	4	4
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0	0	0	0	0	0	0
Depreciation	4	4	5	4	5	4	4	7	8	8	7	7	7	6	8	7	10	4	6	6	7	7	7	6	6	-0	5	6	6	6	6	6
Profit before tax	52	60	18	63	68	53	51	77	86	26	44	74	60	65	55	87	105	79	44	88	100	63	23	111	122	-43	89	119	109	133	129	150
Tax	19	19	4	23	23	17	13	18	19	10	10	19	15	14	13	23	28	19	14	22	28	16	6	29	31	-13	23	30	31	39	33	39
Net profit	0	0	0	41	44	36	38	59	68	16	34	55	45	51	41	64	77	59	30	66	72	47	17	82	91	-30	66	89	78	95	96	112
EPS ₹	29.10	31.52	430.94	24.52	26.56	21.54	23.02	35.70	40.90	9.50	20.40	33.40	27.00	30.80	24.80	38.30	46.30	35.70	17.96	39.50	43.40	28.00	10.11	49.60	54.76	-17.90	39.87	53.34	46.74	56.99	57.92	67.18
Revenue YoY	—	—	—	—	6.1%	-0.4%	15.8%	17.2%	1.5%	—	—	3.3%	15.7%	22.2%	3.7%	9.1%	11.5%	19.8%	1.8%	2.5%	0.0%	-21.3%	-5.7%	2.8%	-0.1%	-99.5%	19.3%	3.7%	20.7%	30264.8%	7.4%	17.7%
Profit YoY	—	—	—	—	—	—	—	65.7%	77.6%	—	—	-6.6%	-33.9%	224.4%	21.5%	15.0%	71.3%	15.7%	-27.6%	3.0%	-6.2%	-21.3%	-43.7%	25.6%	26.1%	-163.8%	294.4%	7.5%	-14.6%	—	45.3%	25.9%

Earlier results (standalone, Sep '07 – Mar '18)

₹ crore · from BSE, before the NSE XBRL filings begin

Procter & Gamble Health Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	Dec '08†	Dec '09†	Dec '11†	Dec '12†	Dec '13†	Dec '14†	Dec '15†	Dec '16†	Dec '17†
Revenue	390	473	560	678	798	867	940	996	1,119
Operating profit	50	61	43	96	77	59	83	114	138
Operating margin	12.8%	12.9%	7.7%	14.2%	9.6%	6.8%	8.9%	11.4%	12.3%
Other income	47	43	46	29	21	20	23	24	24
Interest	0	0	0	—	—	—	—	—	—
Depreciation	6	8	8	9	10	13	23	28	26
Profit before tax	92	96	96	117	88	67	83	110	152
Tax	29	31	32	38	32	23	30	34	58
Net profit	63	65	64	78	56	43	54	76	94

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†
Revenue	82	80	83	105	108	93	99	135	130	109	104	122	157	116	153	164	127	137	185	188	168	182	206	207	202	194	239	221	214	199	247	256	237	218	258	269	252	237	266	313	304	301
Operating profit	18	16	14	16	16	3	5	10	25	21	14	19	34	10	16	21	-4	7	28	36	25	17	22	22	15	4	30	24	0	13	26	19	25	17	27	45	25	23	28	57	31	42
Operating margin	22.1%	19.5%	17.1%	15.7%	14.9%	3.4%	5.0%	7.4%	18.9%	19.5%	13.4%	15.7%	21.4%	8.5%	10.5%	13.0%	-3.4%	5.3%	15.0%	19.2%	15.1%	9.6%	10.9%	10.5%	7.5%	2.1%	12.6%	11.0%	0.2%	6.5%	10.7%	7.5%	10.5%	7.9%	10.3%	16.8%	9.8%	9.6%	10.4%	18.1%	10.1%	13.8%
Other income	11	11	11	11	11	15	11	11	12	10	11	10	12	11	12	11	12	13	5	5	6	6	5	5	5	5	5	5	6	5	5	6	7	5	7	4	8	7	5	6	5	5
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0	—	—	—	—
Depreciation	2	2	1	1	1	2	2	2	2	2	2	2	1	1	1	2	3	2	2	2	2	2	2	2	3	3	3	3	4	4	5	5	8	6	6	6	9	6	6	7	7	9
Profit before tax	28	25	24	26	26	16	14	19	34	29	23	28	34	20	26	31	19	19	31	39	29	21	26	24	18	6	32	27	2	13	26	20	23	16	27	43	24	23	27	56	46	45
Tax	8	7	7	8	8	5	6	7	8	10	8	9	10	6	9	11	6	6	10	13	9	7	9	9	8	2	11	9	1	4	9	8	9	4	9	15	6	8	7	25	19	22
Net profit	19	17	16	18	18	11	9	12	26	19	15	18	25	13	18	20	13	12	20	26	20	14	17	16	9	4	21	18	1	10	17	13	15	12	18	28	18	15	20	32	27	23
EPS ₹	11.37	10.33	9.80	10.68	10.43	6.66	5.11	7.05	15.76	11.35	9.25	11.12	14.92	8.07	10.62	12.05	7.63	7.47	12.14	15.54	12.08	8.42	10.05	9.50	5.69	2.14	12.65	10.59	0.65	5.80	10.16	7.54	8.78	7.38	10.79	16.59	10.97	8.93	12.12	19.09	16.43	13.68
Revenue YoY	—	—	—	—	31.9%	17.3%	18.6%	28.9%	20.7%	16.5%	5.2%	-10.1%	20.8%	11.5%	25.6%	4.3%	—	18.3%	21.2%	14.6%	31.8%	32.7%	11.2%	10.4%	20.7%	6.4%	15.9%	6.5%	5.8%	2.6%	3.6%	15.8%	10.9%	9.8%	4.2%	5.0%	5.9%	8.6%	3.1%	16.3%	20.9%	27.1%
Profit YoY	—	—	—	—	-8.2%	-35.5%	-46.8%	-34.0%	48.7%	67.7%	78.4%	55.4%	-5.4%	-12.8%	-4.6%	-19.3%	—	-7.5%	14.4%	29.1%	58.4%	12.8%	-17.2%	-38.8%	-52.9%	-74.5%	25.9%	11.4%	-88.5%	170.2%	-19.7%	-28.8%	1236.7%	27.3%	6.2%	120.0%	25.0%	21.1%	12.5%	15.1%	49.8%	53.1%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 26 periods

	MAR '19	JUN '19	SEP '19	DEC '19	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	31.2%	32.6%	31.7%	32.8%	30.6%	30.8%	28.1%	26.6%	37.3%	40.5%	38.8%	29.9%	39.1%	34.8%	32.7%	62.3%	68.0%	57.7%
ROCE	—	—	—	—	—	—	—	—	41.2%	43.2%	42.4%	44.3%	41.9%	42.1%	38.6%	36.6%	50.9%	55.2%	52.3%	39.7%	52.0%	46.3%	44.2%	85.9%	93.6%	79.3%
Net margin	4.6%	9.5%	13.5%	17.1%	17.5%	17.0%	14.2%	16.8%	17.3%	17.6%	19.9%	19.7%	18.7%	18.7%	18.3%	18.3%	17.5%	18.8%	20.4%	17.6%	21.8%	22.2%	19.5%	23.2%	24.9%	25.5%
EBITDA margin	19.7%	19.9%	19.0%	22.0%	24.4%	24.2%	20.8%	23.3%	24.1%	24.7%	28.2%	27.6%	26.3%	26.0%	25.3%	25.9%	26.6%	28.6%	30.5%	26.8%	29.6%	29.9%	26.8%	32.4%	32.5%	33.4%
Debt / equity	—	—	—	—	—	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest coverage	—	—	—	—	292.60	329.76	324.06	426.07	604.36	605.41	566.55	524.74	409.05	400.56	414.91	427.99	380.61	430.96	491.22	444.25	697.85	774.95	855.66	818.93	860.95	899.62
Asset turnover	—	—	—	—	—	—	—	—	1.25	1.27	1.08	1.13	1.12	1.12	1.15	1.08	1.45	1.46	1.33	1.14	1.21	1.09	1.16	1.67	1.70	1.47

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 10 periods

	JUN '22	DEC '22	JUN '23	DEC '23	JUN '24	DEC '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	17	17	17	17	17	17	17	17	17	17
Other equity / reserves	600	718	734	789	522	594	520	603	508	641
Total equity	616	734	751	806	538	610	537	620	525	658
Borrowings	0	0	0	0	0	0	0	0	0	0
Current liabilities	236	288	304	230	219	220	215	222	255	297
Non-current liabilities	41	57	46	41	37	40	42	52	62	60
Total assets	894	1,080	1,101	1,077	794	870	794	894	841	1,015
Property, plant & equipment	106	110	130	130	126	110	105	101	99	93
Capital work-in-progress	41	46	32	28	6	8	11	13	14	10
Investments	0	0	0	0	0	0	0	0	0	0
Inventories	115	167	135	129	109	119	109	127	137	137
Receivables	83	102	116	136	85	131	145	137	164	176
Cash & equivalents	319	406	435	421	238	266	182	279	177	323

Cash flow

annual · ₹ crore · line = free cash flow

	Jun '21	Jun '22	Jun '23	Jun '24	FY26
Cash from operations	247	170	236	228	338
Cash from investing	-32	-26	-22	-7	1
Cash from financing	-387	-289	-98	-418	-344
Capex	53	38	42	22	16
Free cash flow	195	132	194	207	322
Dividends paid	382	284	94	415	340

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹93 cr9%

CWIP

₹10 cr1%

Inventories

₹137 cr13%

Receivables

₹176 cr17%

Cash & equivalents

₹323 cr32%

Other assets

₹276 cr27%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Procter & Gamble Health Limited	9,223	5,556.00	24.3	14.02	57.7%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+6.2%

6 months+4.4%

1 year-10.2%

3Y CAGR+2.9%

5Y CAGR+0.6%

10Y CAGR+21.2%

50-day avg₹5,453.77

200-day avg₹5,583.68

RSI (14)62

FAQs

What is the share price of Procter & Gamble Health Limited?

Procter & Gamble Health Limited (PGHL) closed at ₹5,556.00 on NSE on 06 Nov 2026.

What is the market cap of Procter & Gamble Health Limited?

₹9,223 crore at the latest close.

What is the P/E ratio of Procter & Gamble Health Limited?

24.3, on trailing-twelve-month earnings from its filings.

How fast is Procter & Gamble Health Limited growing?

Procter & Gamble Health Limited: revenue has compounded at 8.1% a year over three years; net profit at 19.3% a year. Latest-quarter revenue is up 17.7% year on year, profit up 25.9%.

How profitable is Procter & Gamble Health Limited?

On a trailing-twelve-month basis return on equity is 57.7%, return on capital employed 79.3%, operating margin 33.4%, net margin 25.5%.

How much debt does Procter & Gamble Health Limited have?

Procter & Gamble Health Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹323 cr (balance sheet of 2026-09-30). Operating profit covers interest 899.6 times.

Financials parsed from Procter & Gamble Health Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from JUN '18, annual from Dec '18, balance sheet from Jun '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.